The aim of the research was to determine the intestinal carriers of C. difficile in different human population groups in Serbia. The research enrolled 877 persons with formed stools: (newborn children in maternity hospitals for up to two weeks old) (23), group A; children aged from two weeks to two years (121), group B; children aged two to 10 years (54), group C, healthy individuals aged 10 and over (516), group D; patients hospitalized for at least 48 hours (100), group E; staff of the Clinical Center in Nis, Serbia, (63), group F. The toxins A and B of C. difficile were detected by ELISA-ridascreen Clostridium difficile Toxin A/B
Introduction
Clostridium (C.) difficile is an anaerobic, gram-positive, sporogenic bacterium, which is commonly present in the intestinal tract of animals, healthy children and adults [1] .
Numerous medical researchers [1] [2] [3] believe that there are two kinds of C. difficile strains: toxigenic and non-toxigenic. Toxigenic C. difficile may excrete two exotoxins, enterotoxin (toxin A) and citotoxin (toxin B).
Toxigenic C. difficile has been considered to produce both toxins (A+/B+). However, the results of researches in the last fifteen years suggested that clinically significant strains which could excrete only toxin B (A-/B+) might exist [1] .
Toxigenic C. difficile could be found in the intestines of healthy individuals (asymptomatic carriage/ colonization), but in those with the risk factors (use of antibiotics, older age, long hospitalization, multiple comorbid conditions etc.) it could cause diarrhea of different severity, up to the life-threatening pseudomembranous colitis (Clostridium difficile associated disease -CDAD) [1] .
Previous studies have shown that C. difficile (toxigenic and nontoxigenic) can be found in stool samples of up to 80% of the children in their first year of life, without any clinically significant manifestations [2] . During life, the rate of carrier status drops, so that the bacterial species is commonly found in the intestines of 2-3% of adults, depending on the geographic area, number and age, as well as on the applied research methodology [3] . Asymptomatic intestinal carrier status of C. difficile in adults in hospitals is higher and reaches even 30% [4, 5] .
According to the available data from published and electronic literature, until the present day, the investigation of carriers of these for human medicine important bacterial species has not been conducted in Serbia.
The aim of the research was to determine the intestinal carriership of C. difficile in different human population groups.
Material and methods
The research was done in the period May 2006-October 2011, and included 877 persons with formed stools, classified into the following groups: 1. newborn children (staying in maternity hospitals for up to two weeks) (23), group A 2. children aged from two weeks to two years (121), group B 3. children aged two to 10 years (54), group C 4. healthy individuals aged 10 years and over (516), group D 5. patients hospitalized for at least 48 hours (100), group E 6. staff of the Clinical Center in Nis (doctors, medical staff with higher and secondary education, paramedical staff) (63). Group F During the research, we prospectively collected basic information on sex, age and place of residence of the examinees.
Isolation and identification of C. difficile:
The stool specimens were taken from patients with standard cartridge for stool cultures. The samples were seeded in the laboratory on the selective CCF [cykloserin (500μg/mL), cefoxitin (16μg/mL), fructose] agar (Biomedics, Parg qe tehnicologico, Madrid, Spain) for C. difficile cultivation. Then, the CCF agar was incubated at 37 o C under anaerobic conditions for 48 h. AnaeroGen sachets (OXOID, Cambridge, England) were used to create anaerobic condition in anaerobic jars. Anaerobic strips (Anaerobic indicator, OXOID, Cambridge, England) were used to verify anaerobic conditions.
Biochemical identification of C. difficile isolates (with typical colonies measuring 4 mm or more in diameter, elevated, convex, with a discrete margin, an irregular surface and strong horse manure-like odor) was performed using the API system for anaerobic bacteria (API 20A BioMerieux, Paris, France).
For the identification of isolates agglutination Culture CDT Rapid Latex Test Kit (Becton Dickinson, New Jersey, USA) was used, detecting of C. difficile antigen.
Examination of toxin production of C. difficile:
The colonies of C. difficile were subcultivated in 5 ml brain-heart infusion broth under anaerobic conditions during four days (1 day = 24 h ). After incubation, liquid cultures of C. difficile were centrifugated at 3000 g for 15 min.
C. difficile toxins A and B were detected in the supernatant by ELISA-ridascreen Clostridium difficile Toxin A/B (R-Biopharm AG, Darmstadt, Germany), containing the antibodies against the toxin A and toxin B, as per the manufacturer's instructions.
C. difficile toxin A was detected in the supernatant using ColorPAC Toxin A test (Becton Dickinson, New Jersey, USA), containing only the antibodies against the toxin A, as per the manufacturer's instructions.
The same procedure was applied for liquid cultures of reference strains C. difficile ATCC 43598 (A-/B+) and C. difficile ATCC 43255 (A+/B+) cultivated in brain-heart infusion broth under anaerobic conditions within four days (1 day = 24 h ).
Statistical analysis
SPSS (version 15) statistical package was used for statistical analysis (chi-square test). A p-value less than 0.05 was considered as significant.
Results
During the study, we examined 877 stool samples obtained from 877 persons aged from one week to 84 years (51.54% male and 48.46% female). Most persons (728 (83%)) had a residence in the city of Nis and south Serbia, a small number of persons (96 (11%)) resided in the territory of central Serbia, while 35 (4%) were from the Belgrade area. The smallest number of persons (18 (2%)) resided in the territory of the Autonomous Province of Vojvodina (northern Serbia). Basic demographic data on persons of individual groups are shown in Table 1 . From the samples of 70 (7.98%) persons, C. difficile was cultivated. The percentage of persons with C. difficile by followed groups ranged from 1.75-47.83% (Table 1) . The testing by C. difficile toxin production found that 75.71% of the isolates did not produce toxins (A-/B-), while 22.86% produced toxin A and toxin B (A+/B+). One (1.43%) isolate produced only toxin B (A-/B+) ( Table 2) .
Distribution of persons by the toxin-producing type of C. difficile is shown in Table 3 . In most of the groups (5 / 6), the predominance of non-toxigenic (A-/B-) isolates was established, with the rate of carriers of 1.75-30.43% depending on the group. Toxigenic isolates were prevalent only in the group F in relation to non-toxigenic (7.94% versus 4.76% of persons). In other groups the carriers of toxigenic strains ranged from 1.65-17.45%, provided that in the group D, the carriers of toxigenic strains were not found. In one person (1.59%) in group F, the presence of isolates that produce only toxin B (A-/ B+) was detected. Out of the total number of persons (877), the carriers of certain types of toxin-producing strains of C. difficile was 6.04% (A-/B-), 1.83% (A+/B+) and 0.11% (A-/B+). 
Discussion
Colonization of the human intestine with C. difficile starts immediately after birth from multiple sources. Bolton R. et al. [2] believe that the most likely way of colonization of the intestinal tract is the intake of strains from the hospital environment where children are born. This claim was supported with the results of a study in which C. difficile was found in 3.2% of the swabs of the items surrounding a newborns baby in the hospital room [6] . Molecular microbiological methods by Japanese researches confirmed the presence of the same PFGE and PCR types in the samples of flooring and hospital environment and those found in the intestine of a newborn one week old. However, the results indicated the presence of certain PFGE and PCR types of C. difficile of feces samples characteristic for their mother intestine, but which were not found in the hospital [7] . During the first months of life, the intestinal tract of up to 80% of children is colonized by C. difficile (toxigenic and nontoxigenic strains) [2, 7] . Larson H. et al. [6] determined that the carriers of C. difficile in newborns are different, depending on the institution in which they were born (in three hospitals, with the same methods of cultivation, the rate of carriers was 2-52%). The carriership of toxigenic strains ranged from 10-55% in children, depending on the research. There were no sings and symptoms of CDAD in these children, which can be explaned by the deficiency of receptors for toxins or their being masked in that period of life [7, 8] .
High rate of carriership remains for the first months of life and then decreases to the usual 2-3% in adults [3, 9] . The highest rate of carriership of 17.5% in healthy adults was observed in Japan by Nakamura S. et al. [10] . In contrast to these data, Larson H. et al. [11] did not identify carriers of C. difficile in adults. The carriership of only toxigenic strains in healthy adults ranged from 0 -13.26% [3, [10] [11] [12] .
The results of this research agree with the majority of published studies, because the highest rate of carriership of C. difficile (47.83%) was observed among the children younger than 2 weeks. The decline of carriership with age was noted in this study because this bacteria was found in stool samples of nine persons aged ten years and over. The reason for the falling rates of carriership with aging remains unclear, but there are indications that intestinal colonization by other normal flora leads to the inhibition of colonization or growth of C. difficile [7] .
The difference in the rate of intestinal carriership of C.difficile in this study compared to the high rate of cariers in other studies [3, 7, 10] may be in a large number of examined samples of feces (up to seven). Also, the examinees were continually monitored for several months using the methodology of sample cultivation, allowing for a maximum germination of spores. It should be noted that in these studies the cumulative carrier status was reported, although in many of the tested it was noted that there was only one sample positive for C. difficile, and several samples were negative after that. In these studies [3, 7, 10] , a lower rate of carriership was found (as in our study) if the observed period of time included two samplings per person.
A particular aspect of carriership of C. difficile is the presence of the species in the intestinal tract of hospitalized patients and medical staff. A stay in hospital signifficantly affects the intestinal colonization of humans by C. difficile. This is confimed by prospective studies that there were 5.9-11% of asymptomatic carriers of C. difficile among patients the hospitalized for one to two weeks [9, 13] . This is higher than 3%, which usually occurs in healthy adults and can be caused by the use of antibiotics and colonization during previous hospitalizations. The analysis of epidemiological studies showed that there was a difference in the rate of carriership depending on the patient type. Asymptomatic carriership was found in 7% of patients hospitalized for a long time in a general ward [13] , 14% of elderly patients hospitalized in the intensive care unit [14] and 20% of elderly patients hospitalized for chronic illnesses and in need of other care and assistance or for the maintenance of vital functions [15] . Some studies indicated that among hospitalized patients older than 65 years, the rate of carriership was even up to 30% [4, 5] . Most isolates (to 80%) obtained from hospitalized patients produced toxins. The persons and hospitalized patients with asymptomatic carriership of C. difficile, as well as the patients with CDAD, represent an important reservoir of this bacteria and could contaminate the environment (especially hospital units) with C. difficile spores or vegetative forms [15] . Spores of C. difficile can persist on hospital surfaces for months (e.g. floor, furniture, medical equipments etc.) allowing for an easy transmission of the infection [16] . Numerous studies have shown the contamination rate of 8% by spores of C. difficile in specimens obtained from hospital rooms, despite regular control of hospital cleaning [15, 16] . These studies demonstrated higher contamination rates with spores of C. difficile in the hospital rooms where there were patients with manifested CDAD in comparison with rooms with asymptomatic carriers of C. difficile (49% and 29%, respectively) [15] . Clabots R. et al. [17] , using the molecular typing methods, showed that 84% of hospital CDAD cases caused by C. difficile originated from hospital rooms or the intestines of asymptomatic patients.
The vegetative or spore form of C. difficile can be transmitted from contaminated surfaces or objects to patients via dirty hands of medical personnel. There are publications of positive hand cultures in 59% of the medical staff [15] . The spread of infection is easy because of the resistant nature of C. difficile spores to disinfectants and antiseptics commonly used in hospitals, as well as to antibiotics. Some studies indicated that it was possible to directly introduce of C. difficile in to the intestinal tract with contaminated objects (e.g. thermometer) [18] . Moving patients from one patient room to another or to some other unit or hospital may also cause transmission of the disease [18] .
Since hospital medical staff are exposed to C. difficile spores, and have a constant contact with asymptomatic carriership and patients with manifested CDAD, the rates of intestinal carriers are significantly increased within this population group (5-14% of investigated people) [3] in comparison to the adults outside hospitals (2-3%). It should be noted that some studies have reported a high prevalence of toxigenic strains of C. difficile in this population group (up to 100%) [3] . Similarly, in our study we found that the prevalence rate was 12.70% and only in this studied group the toxigenic strains were dominant.
Considering that asymptomatic carriership of C. difficile could be a source of CDAD spread, there are suggestions that these individuals should be treated with antibiotic therapy. However, most researchers agree that these individuals do not require the use of antibiotics, because attempts made so far to eradicate carriers by vancomycin and metronidazole have been unsuccessful [19] . In addition, some researchers have confirmed that asymptomatic carrier status of C. difficile can prevent CDAD. Serum and local (mucosal) antibodies against C. difficile toxins appeared as an immune response to the presence of C. difficile in 60% of investigated persons and this finding is in correlation with the decreasing risk for CDAD. On the contrary, patients with intestinal colonization by toxigenic strains of C. difficile and low levels of serum IgG antibody to toxin A have an increased risk for CDAD. This risk is markedly increased if the patient has a severe baseline disease [20] . Some researchers believe that asymptomatic carriers of C. difficile should be treated only if they have direct contact with the group of patients with high risk for CDAD [19. 
Conclusion
This study showed that asymptomatic intestinal carriership of C. difficile, in Serbian population, ranged from 1.75-47.83%. The carriers of toxigenic strains were detected only in 1.65-17.45% of cases, depending on the studied group. The presence of asymptomatic intestinal carriers of C. difficile in the Serbian population, indicates the possible reservoirs and sources of infections caused by this bacterial species in and outside the hospital setting. Future studies, using more modern microbiological methods, and comparison with the isolates obtained from patients with CDAD will reveal the transmission routes of C. difficile and the possibility of cross infection in our geographical area.
